SCNN1D
geneOn this page
Also known as ENaCdeltadNaCh
Summary
SCNN1D (sodium channel epithelial 1 subunit delta, HGNC:10601) is a protein-coding gene on chromosome 1p36.33, encoding Epithelial sodium channel subunit delta (P51172). Potential alternative pore-forming subunit of the epithelial sodium channel (ENaC), capable of replacing the alpha/SCNN1A subunit, creating a more active channel with distinct properties.
Contributes to sodium channel activity. Involved in cellular response to acidic pH; intracellular sodium ion homeostasis; and sodium ion import across plasma membrane. Located in actin cytoskeleton and membrane. Part of sodium channel complex. Is active in apical plasma membrane.
Source: NCBI Gene 6339 — RefSeq curated summary.
At a glance
- GWAS associations: 3
- Clinical variants (ClinVar): 139 total
- MANE Select transcript:
NM_001130413
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:10601 |
| Approved symbol | SCNN1D |
| Name | sodium channel epithelial 1 subunit delta |
| Location | 1p36.33 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | ENaCdelta, dNaCh |
| Ensembl gene | ENSG00000162572 |
| Ensembl biotype | protein_coding |
| OMIM | 601328 |
| Entrez | 6339 |
Gene structure
Transcript identifiers
Ensembl transcripts: 8 — 6 protein_coding, 1 nonsense_mediated_decay, 1 protein_coding_CDS_not_defined
ENST00000325425, ENST00000338555, ENST00000379099, ENST00000379101, ENST00000379116, ENST00000400928, ENST00000467651, ENST00000470022
RefSeq mRNA: 1 — MANE Select: NM_001130413
NM_001130413
CCDS: CCDS44037
Canonical transcript exons
ENST00000379116 — 18 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001562666 | 1291254 | 1292025 |
| ENSE00002414944 | 1280436 | 1280666 |
| ENSE00003253818 | 1281411 | 1281610 |
| ENSE00003396173 | 1281226 | 1281297 |
| ENSE00003412670 | 1285571 | 1285664 |
| ENSE00003480639 | 1287673 | 1287836 |
| ENSE00003503328 | 1290637 | 1290694 |
| ENSE00003547655 | 1291065 | 1291140 |
| ENSE00003559189 | 1287939 | 1288037 |
| ENSE00003562830 | 1282242 | 1282315 |
| ENSE00003580183 | 1286768 | 1286975 |
| ENSE00003620052 | 1287109 | 1287299 |
| ENSE00003623933 | 1290477 | 1290555 |
| ENSE00003669557 | 1290271 | 1290388 |
| ENSE00003678929 | 1287508 | 1287596 |
| ENSE00003681943 | 1285926 | 1286278 |
| ENSE00003683030 | 1283978 | 1284090 |
| ENSE00003689163 | 1290895 | 1290953 |
Expression profiles
Bgee: expression breadth ubiquitous, 161 present calls, max score 92.03.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 3.0916 / max 68.7528, expressed in 1221 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 78 | 2.6630 | 1148 |
| 79 | 0.3796 | 209 |
| 80 | 0.0490 | 17 |
Top tissues by expression
291 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| right hemisphere of cerebellum | UBERON:0014890 | 92.03 | gold quality |
| right testis | UBERON:0004534 | 91.94 | gold quality |
| left testis | UBERON:0004533 | 91.23 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 90.95 | gold quality |
| cerebellar cortex | UBERON:0002129 | 90.75 | gold quality |
| right uterine tube | UBERON:0001302 | 90.39 | gold quality |
| cerebellum | UBERON:0002037 | 87.51 | gold quality |
| right frontal lobe | UBERON:0002810 | 87.41 | gold quality |
| testis | UBERON:0000473 | 86.20 | gold quality |
| apex of heart | UBERON:0002098 | 85.64 | gold quality |
| adenohypophysis | UBERON:0002196 | 84.92 | gold quality |
| paraflocculus | UBERON:0005351 | 84.15 | silver quality |
| left ovary | UBERON:0002119 | 83.91 | gold quality |
| right ovary | UBERON:0002118 | 83.84 | gold quality |
| cingulate cortex | UBERON:0003027 | 83.37 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 83.36 | gold quality |
| pituitary gland | UBERON:0000007 | 83.18 | gold quality |
| left uterine tube | UBERON:0001303 | 82.87 | gold quality |
| right lobe of liver | UBERON:0001114 | 82.82 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 82.53 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 82.51 | gold quality |
| middle frontal gyrus | UBERON:0002702 | 82.48 | silver quality |
| frontal pole | UBERON:0002795 | 82.44 | gold quality |
| sural nerve | UBERON:0015488 | 82.35 | gold quality |
| nucleus accumbens | UBERON:0001882 | 82.00 | gold quality |
| ventricular zone | UBERON:0003053 | 81.24 | gold quality |
| amygdala | UBERON:0001876 | 80.85 | gold quality |
| body of uterus | UBERON:0009853 | 80.70 | gold quality |
| putamen | UBERON:0001874 | 80.30 | gold quality |
| caudate nucleus | UBERON:0001873 | 80.22 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 2.30 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 28)
- Study identified a stringent requirement for Mre11-Rad50-Nbs (MRN) function in telomere protection during early embryonic development. (PMID:19520832)
- NBS1 interacts with HP1 to ensure genome integrity. (PMID:31836699)
- The Mre11-Rad50-Nbs1 complex mediates the robust recruitment of Polo to DNA lesions during mitosis in Drosophila. (PMID:32487663)
- delta ENaC is regulated by Murr1 (PMID:14645214)
- ENaCdelta activity is regulated by protons, and may contribute to the pH sensation and/or pH regulation in the human brain (PMID:14726523)
- delta ENaC is a proton sensor (PMID:15084585)
- ENaCdelta is chemically activated by capsazepine by a proton-dependent mechanism (PMID:15308635)
- the interactions of delta-ENaC with alpha beta gamma-human epithelial sodium channel subunits could account for heterogeneity of native epithelial channels (PMID:16423824)
- analysis of anovel spliced variant of the ENaC delta-subunit in the human brain (PMID:16930535)
- ENaC delta isoforms are widely expressed in pyramidal cells of the human and monkey cerebral cortex and in different neuronal populations of telencephalic subcortical nuclei. (PMID:17472699)
- Expression analyses at the level of mRNA clearly revealed that ENaC delta transcript was strongly expressed in human melanoma cells using reverse transcription-polymerase chain reaction and cell-based in situ hybridization techniques. (PMID:18073141)
- EIPA [5-(N-ethyl-N-isopropyl)-amiloride hydrochloride] inhibition of ENaCs, possibly ENaC-alpha and ENaC-delta, significantly improved the sperm motility in healthy donors and in asthenospermia patients. (PMID:18298571)
- ENaCdelta is a candidate molecule for pH sensing in the gastrointestinal system in humans, providing a novel therapeutic target for gastro-oesophageal reflux disease (PMID:18951889)
- Regulation of epithelial sodium channels by cGMP/PKGII. (PMID:19359370)
- the delta-subunit of ENaC alters proteolytic channel activation and enhances base-line channel activity (PMID:19717556)
- Data support a physiological role for SGK1.1 in the regulation of delta-ENaC through a pathway that differs from the classical one and suggest that the kinase could serve as an integrator of different signaling pathways converging on the channel. (PMID:20631247)
- Identify the specific domains of epithelial sodium channels that are responsible for the differences in the response to flow of alphabetagamma and deltabetagamma channels. (PMID:21307123)
- Cpt-cAMP activates human epithelial sodium channels via relieving self-inhibition. (PMID:21419751)
- CPT-cGMP Stimulates Human Alveolar Fluid Clearance by Releasing External Na+ Self-Inhibition of ENaC. (PMID:21562313)
- These results suggest that COMMD1 downregulates deltaENaC activity by reducing deltaENaC surface expression through promoting internalization of surface deltaENaC to an intracellular recycling pool, possibly via enhanced ubiquitination. (PMID:21741370)
- delta-ENaC undergoes dynamin-independent endocytosis as opposed to alphabetagamma-channels. (PMID:22159085)
- study characterized a new variant, delta2 ENaC, in lung epithelial cells; heterologous delta2betagamma ENaC exhibited a number of divergent features from the delta1betagamma counterpart in biophysics and pharmacology, regulation, and the lifespan of proteins (PMID:22505667)
- delta-ENaC expression is low in NCI-H441, Calu-3, and ATI cells and does not contribute to transepithelial sodium absorption (PMID:25677639)
- deltabetagamma-ENaC is inhibited by CFTR but activated by cyclic AMP. (PMID:27941075)
- The Epithelial Sodium Channel Is a Modifier of the Long-Term Nonprogressive Phenotype Associated with F508del CFTR Mutations (PMID:28708422)
- Proliferative regulation of alveolar epithelial type 2 progenitor cells by human Scnn1d gene. (PMID:31754387)
- CRISPR/Cas9 Mediated Knock Down of delta-ENaC Blunted the TNF-Induced Activation of ENaC in A549 Cells. (PMID:33673381)
- Rare Variants in Genes Encoding Subunits of the Epithelial Na[+] Channel Are Associated With Blood Pressure and Kidney Function. (PMID:36193739)
Cross-species orthologs
24 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| drosophila_melanogaster | Nach | FBGN0024319 |
| drosophila_melanogaster | ppk28 | FBGN0030795 |
| drosophila_melanogaster | ppk17 | FBGN0032602 |
| drosophila_melanogaster | ppk6 | FBGN0034489 |
| drosophila_melanogaster | ppk12 | FBGN0034730 |
| drosophila_melanogaster | ppk29 | FBGN0034965 |
| drosophila_melanogaster | ppk24 | FBGN0039839 |
| drosophila_melanogaster | ppk22 | FBGN0051105 |
| drosophila_melanogaster | ppk8 | FBGN0052792 |
| drosophila_melanogaster | ppk5 | FBGN0053289 |
| drosophila_melanogaster | ppk16 | FBGN0065108 |
| drosophila_melanogaster | ppk11 | FBGN0065109 |
| drosophila_melanogaster | ppk9 | FBGN0085398 |
| drosophila_melanogaster | ppk18 | FBGN0265001 |
| caenorhabditis_elegans | WBGENE00003168 | |
| caenorhabditis_elegans | WBGENE00003174 | |
| caenorhabditis_elegans | WBGENE00007518 | |
| caenorhabditis_elegans | WBGENE00009073 | |
| caenorhabditis_elegans | WBGENE00011891 | |
| caenorhabditis_elegans | delm-2 | WBGENE00016063 |
| caenorhabditis_elegans | acd-1 | WBGENE00016064 |
| caenorhabditis_elegans | acd-2 | WBGENE00016066 |
| caenorhabditis_elegans | WBGENE00016699 | |
| caenorhabditis_elegans | WBGENE00017879 |
Paralogs (8): ASIC4 (ENSG00000072182), ASIC2 (ENSG00000108684), ASIC1 (ENSG00000110881), SCNN1A (ENSG00000111319), SCNN1G (ENSG00000166828), SCNN1B (ENSG00000168447), ASIC3 (ENSG00000213199), ASIC5 (ENSG00000256394)
Protein
Protein identifiers
Epithelial sodium channel subunit delta — P51172 (reviewed: P51172)
Alternative names: Amiloride-sensitive sodium channel subunit delta, Delta-NaCH, Nonvoltage-gated sodium channel 1 subunit delta, SCNED
All UniProt accessions (4): C9JDY8, F8VWH5, P51172, H0Y3F1
UniProt curated annotations — full annotation on UniProt →
Function. Potential alternative pore-forming subunit of the epithelial sodium channel (ENaC), capable of replacing the alpha/SCNN1A subunit, creating a more active channel with distinct properties. ENaC functions in epithelial tissues, where it facilitates the electrodiffusion of sodium ions from the extracellular fluid through the apical membrane of cells, with water following osmotically, regulating sodium balance and fluid homeostasis. This subunit could also function independently as a sodium channel or assemble into other tissue-specific heterotrimeric sodium channels. ENaC channels including this isoform exhibit greater conductance.
Subunit / interactions. Can form an alternative heterotrimeric epithelial sodium channel (ENaC), composed of a delta (SCNN1D), beta (SCNN1B), and gamma (SCNN1G) subunit, where the delta (SCNN1D) subunit replaces the alpha (SCNN1A) subunit.
Subcellular location. Apical cell membrane.
Tissue specificity. Not specifically expressed in epithelial cells.
Activity regulation. Originally identified and characterized by its inhibition by the diuretic drug amiloride.
Miscellaneous. The additional delta/SCNN1D subunit exists only in some organisms.
Similarity. Belongs to the amiloride-sensitive sodium channel (TC 1.A.6) family. SCNN1D subfamily.
Isoforms (3)
| UniProt ID | Names | Canonical? |
|---|---|---|
| P51172-3 | 3 | yes |
| P51172-1 | 1, delta1 | |
| P51172-2 | 2, delta2 |
RefSeq proteins (1): NP_001123885* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001873 | ENaC | Family |
| IPR004724 | ENaC_chordates | Family |
| IPR020903 | ENaC_CS | Conserved_site |
Pfam: PF00858
Catalyzed reactions (Rhea), 1 shown:
- Na(+)(in) = Na(+)(out) (RHEA:34963)
UniProt features (60 total): strand 20, helix 9, sequence variant 6, sequence conflict 5, turn 5, topological domain 3, splice variant 3, glycosylation site 2, transmembrane region 2, region of interest 2, compositionally biased region 2, chain 1
Structure
Experimental structures (PDB)
1 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 9BLR | ELECTRON MICROSCOPY | 3.38 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-P51172-F1 | 66.84 | 0.26 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Glycosylation sites (2): 330, 548
Function
Pathways and Gene Ontology
Reactome pathways
6 pathways
| ID | Pathway |
|---|---|
| R-HSA-2672351 | Stimuli-sensing channels |
| R-HSA-9730628 | Sensory perception of salty taste |
| R-HSA-382551 | Transport of small molecules |
| R-HSA-9709957 | Sensory Perception |
| R-HSA-9717189 | Sensory perception of taste |
| R-HSA-983712 | Ion channel transport |
MSigDB gene sets: 102 (showing top):
GOBP_RESPONSE_TO_NITROGEN_COMPOUND, GOBP_REGULATION_OF_BLOOD_PRESSURE, GOBP_CIRCULATORY_SYSTEM_PROCESS, GOBP_CELLULAR_RESPONSE_TO_LIPID, GOBP_RESPONSE_TO_CORTICOSTEROID, GOBP_SODIUM_ION_TRANSMEMBRANE_TRANSPORT, GOBP_SENSORY_PERCEPTION_OF_CHEMICAL_STIMULUS, GOBP_CELLULAR_RESPONSE_TO_OXYGEN_CONTAINING_COMPOUND, GOBP_MONOATOMIC_CATION_TRANSPORT, GOBP_CELLULAR_RESPONSE_TO_HORMONE_STIMULUS, GOBP_CELLULAR_RESPONSE_TO_CORTICOSTEROID_STIMULUS, GOBP_RESPONSE_TO_KETONE, GOBP_SENSORY_PERCEPTION_OF_TASTE, ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN, GOBP_INTRACELLULAR_SODIUM_ION_HOMEOSTASIS
GO Biological Process (12): intracellular sodium ion homeostasis (GO:0006883), regulation of blood pressure (GO:0008217), sodium ion transmembrane transport (GO:0035725), sensory perception of salty taste (GO:0050914), sensory perception of sour taste (GO:0050915), cellular response to acidic pH (GO:0071468), sodium ion import across plasma membrane (GO:0098719), cellular response to aldosterone (GO:1904045), cellular response to vasopressin (GO:1904117), monoatomic ion transport (GO:0006811), sodium ion transport (GO:0006814), monoatomic ion transmembrane transport (GO:0034220)
GO Molecular Function (3): sodium channel activity (GO:0005272), ligand-gated sodium channel activity (GO:0015280), protein binding (GO:0005515)
GO Cellular Component (5): plasma membrane (GO:0005886), actin cytoskeleton (GO:0015629), membrane (GO:0016020), apical plasma membrane (GO:0016324), sodium channel complex (GO:0034706)
Reactome top-level categories
Rollup of top-4 pathways:
| Category | Pathways |
|---|---|
| Ion channel transport | 1 |
| Sensory perception of taste | 1 |
| Sensory Perception | 1 |
| Transport of small molecules | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| sensory perception of taste | 2 |
| intracellular monoatomic cation homeostasis | 1 |
| sodium ion homeostasis | 1 |
| blood circulation | 1 |
| regulation of biological quality | 1 |
| sodium ion transport | 1 |
| monoatomic cation transmembrane transport | 1 |
| response to acidic pH | 1 |
| cellular response to pH | 1 |
| sodium ion transmembrane transport | 1 |
| inorganic cation import across plasma membrane | 1 |
| cellular response to mineralocorticoid stimulus | 1 |
| cellular response to alcohol | 1 |
| cellular response to aldehyde | 1 |
| cellular response to ketone | 1 |
| response to aldosterone | 1 |
| cellular response to peptide hormone stimulus | 1 |
| response to vasopressin | 1 |
| transport | 1 |
| metal ion transport | 1 |
| monoatomic ion transport | 1 |
| transmembrane transport | 1 |
| monoatomic cation channel activity | 1 |
| sodium ion transmembrane transporter activity | 1 |
| sodium channel activity | 1 |
| ligand-gated monoatomic cation channel activity | 1 |
| binding | 1 |
| membrane | 1 |
| cell periphery | 1 |
| cytoskeleton | 1 |
| cellular anatomical structure | 1 |
| apical part of cell | 1 |
| plasma membrane region | 1 |
| cation channel complex | 1 |
Protein interactions and networks
STRING
787 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| SCNN1D | CYP4A11 | Q02928 | 815 |
| SCNN1D | SCNN1B | P51168 | 711 |
| SCNN1D | PKD2L1 | Q9P0L9 | 591 |
| SCNN1D | ACAP3 | Q96P50 | 577 |
| SCNN1D | SCNN1A | P37088 | 491 |
| SCNN1D | SCNN1G | P51170 | 485 |
| SCNN1D | TAS2R60 | P59551 | 480 |
| SCNN1D | ASIC2 | Q16515 | 468 |
| SCNN1D | ACOT7 | O00154 | 462 |
| SCNN1D | ASIC1 | P78348 | 447 |
| SCNN1D | PKD1L3 | Q7Z443 | 439 |
| SCNN1D | PKD1L1 | Q8TDX9 | 437 |
| SCNN1D | OR2T10 | Q8NGZ9 | 434 |
| SCNN1D | TAS1R2 | Q8TE23 | 420 |
| SCNN1D | TAS2R38 | P59533 | 419 |
IntAct
10 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| SCNN1D | COMMD1 | psi-mi:“MI:0915”(physical association) | 0.580 |
| COMMD1 | SCNN1D | psi-mi:“MI:0915”(physical association) | 0.580 |
| SCNN1D | ABHD16A | psi-mi:“MI:0914”(association) | 0.530 |
| STX11 | EXOC5 | psi-mi:“MI:0914”(association) | 0.530 |
| SCNN1G | SCNN1D | psi-mi:“MI:0915”(physical association) | 0.400 |
| SCNN1A | SCNN1D | psi-mi:“MI:0915”(physical association) | 0.400 |
| STX11 | GOSR1 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (40): SCNN1D (Affinity Capture-MS), ABHD16A (Affinity Capture-MS), MTFR2 (Affinity Capture-MS), TAP2 (Affinity Capture-MS), DPY19L1 (Affinity Capture-MS), CLSTN3 (Affinity Capture-MS), AMIGO1 (Affinity Capture-MS), CFAP74 (Affinity Capture-MS), LRRC3 (Affinity Capture-MS), CLPTM1 (Affinity Capture-MS), ANGEL1 (Affinity Capture-MS), ALG9 (Affinity Capture-MS), ERMP1 (Affinity Capture-MS), LRP12 (Affinity Capture-MS), POMT1 (Affinity Capture-MS)
ESM2 similar proteins: A1L515, A2A9Q0, D3YZZ2, D4A2Q0, E1BDF2, E7ERA6, F2Z333, H3BV60, O43508, O46547, O54907, P0C6B2, P0DH78, P41155, P51172, P70225, Q01113, Q13477, Q14626, Q29RT8, Q5RF19, Q5SZI1, Q5T7M4, Q5U4P2, Q63148, Q64385, Q6AZ51, Q6BAA4, Q6UWL6, Q6UXT9, Q6ZMC9, Q86UR1, Q86YD3, Q8BH06, Q8N1F8, Q8NFR9, Q96G42, Q99640, Q99M75, Q99MF4
Diamond homologs: A5D7U4, F1MJW3, H1AFJ5, H1AFJ6, H1AFJ7, H2Q5A1, H2QAR5, H2QAR6, H9GBX2, K7FQW8, K7FSQ4, K7GET2, O13262, O13263, O62816, O97741, O97742, P37088, P37089, P37090, P37091, P51167, P51168, P51169, P51170, P51171, P51172, P55270, Q21974, Q28738, Q61180, Q92075, Q95165, Q9R1N2, Q9W754, Q9WU38, Q9WU39, O46547, Q09274, O01635
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
139 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 96 |
| Likely benign | 28 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
2187 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 1:1286933:GC:G | donor_gain | 1.0000 |
| 1:1286971:GACTG:G | donor_gain | 1.0000 |
| 1:1286973:CTGGT:C | donor_loss | 1.0000 |
| 1:1286974:TGGT:T | donor_loss | 1.0000 |
| 1:1286975:GGT:G | donor_loss | 1.0000 |
| 1:1286976:G:GG | donor_gain | 1.0000 |
| 1:1286976:GTG:G | donor_loss | 1.0000 |
| 1:1286977:T:A | donor_loss | 1.0000 |
| 1:1287107:A:AG | acceptor_gain | 1.0000 |
| 1:1287107:AGT:A | acceptor_gain | 1.0000 |
| 1:1287108:G:GT | acceptor_gain | 1.0000 |
| 1:1287108:GT:G | acceptor_gain | 1.0000 |
| 1:1287108:GTG:G | acceptor_gain | 1.0000 |
| 1:1287108:GTGC:G | acceptor_gain | 1.0000 |
| 1:1287108:GTGCA:G | acceptor_gain | 1.0000 |
| 1:1287273:T:G | donor_gain | 1.0000 |
| 1:1287295:GCCCG:G | donor_gain | 1.0000 |
| 1:1287296:CCCG:C | donor_gain | 1.0000 |
| 1:1287297:CCG:C | donor_gain | 1.0000 |
| 1:1287297:CCGGT:C | donor_loss | 1.0000 |
| 1:1287298:CGGTG:C | donor_loss | 1.0000 |
| 1:1287300:G:C | donor_loss | 1.0000 |
| 1:1287300:G:GG | donor_gain | 1.0000 |
| 1:1287502:TTCCA:T | acceptor_loss | 1.0000 |
| 1:1287503:TCCA:T | acceptor_loss | 1.0000 |
| 1:1287504:CCAGA:C | acceptor_loss | 1.0000 |
| 1:1287505:CA:C | acceptor_loss | 1.0000 |
| 1:1287506:A:AG | acceptor_gain | 1.0000 |
| 1:1287506:AGAC:A | acceptor_loss | 1.0000 |
| 1:1287507:G:GA | acceptor_gain | 1.0000 |
AlphaMissense
5127 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 1:1287177:G:C | W396C | 0.985 |
| 1:1287177:G:T | W396C | 0.985 |
| 1:1286967:T:C | F371L | 0.982 |
| 1:1286969:C:A | F371L | 0.982 |
| 1:1286969:C:G | F371L | 0.982 |
| 1:1290676:G:C | W633C | 0.981 |
| 1:1290676:G:T | W633C | 0.981 |
| 1:1290387:G:C | W593C | 0.978 |
| 1:1290387:G:T | W593C | 0.978 |
| 1:1286111:G:C | K248N | 0.970 |
| 1:1286111:G:T | K248N | 0.970 |
| 1:1286968:T:C | F371S | 0.969 |
| 1:1290539:T:A | C615S | 0.967 |
| 1:1290540:G:C | C615S | 0.967 |
| 1:1286259:T:A | C298S | 0.965 |
| 1:1286260:G:C | C298S | 0.965 |
| 1:1287175:T:A | W396R | 0.963 |
| 1:1287175:T:C | W396R | 0.963 |
| 1:1290361:T:A | C585S | 0.962 |
| 1:1290362:G:C | C585S | 0.962 |
| 1:1286968:T:G | F371C | 0.960 |
| 1:1290484:C:G | C596W | 0.958 |
| 1:1286251:T:A | V295D | 0.957 |
| 1:1287178:T:G | Y397D | 0.957 |
| 1:1287545:T:A | C450S | 0.957 |
| 1:1287546:G:C | C450S | 0.957 |
| 1:1290363:C:G | C585W | 0.957 |
| 1:1291290:A:C | S697R | 0.957 |
| 1:1291292:C:A | S697R | 0.957 |
| 1:1291292:C:G | S697R | 0.957 |
dbSNP variants (sampled 300 via entrez): RS1000078457 (1:1281723 C>A,G,T), RS1000287515 (1:1292237 G>A), RS1000356415 (1:1288316 TCC>T), RS1000403428 (1:1288151 G>A), RS1000432417 (1:1281818 G>A,T), RS1000466971 (1:1281523 G>A), RS1000467909 (1:1281127 C>A), RS1000769030 (1:1280827 C>T), RS1000801833 (1:1280591 A>G), RS1000953323 (1:1285134 C>A,T), RS1000965875 (1:1288031 C>G,T), RS1001321198 (1:1283884 T>C), RS1001330619 (1:1287379 A>G), RS1001506065 (1:1284539 T>C), RS1001578918 (1:1287772 C>T)
Disease associations
OMIM: gene MIM:601328 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
3 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST004131_103 | Inflammatory bowel disease | 2.000000e-07 |
| GCST004133_40 | Ulcerative colitis | 3.000000e-06 |
| GCST009465_1 | Platelet count | 3.000000e-06 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004309 | platelet count |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
GtoPdb / IUPHAR curated pharmacology
(IUPHAR/BPS Guide to Pharmacology — expert-curated)
Target class: lgic — Epithelial sodium channel (ENaC)
CTD chemical–gene interactions
35 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| aristolochic acid I | increases expression | 1 |
| GSK-J4 | decreases expression | 1 |
| bisphenol A | decreases methylation | 1 |
| sodium arsenate | decreases expression, increases abundance | 1 |
| dimethylselenide | increases oxidation, increases expression | 1 |
| tris(1,3-dichloro-2-propyl)phosphate | increases expression | 1 |
| sodium arsenite | increases expression | 1 |
| benzo(e)pyrene | decreases methylation | 1 |
| 8-((4-chlorophenyl)thio)cyclic-3’,5’-GMP | affects binding, increases activity | 1 |
| 8-(4-chlorophenylthio)guanosine 3’,5’-cyclic monophosphorothioate | affects binding, increases activity | 1 |
| ICG 001 | increases expression | 1 |
| 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide | increases expression, decreases reaction | 1 |
| jinfukang | increases expression | 1 |
| 4-(4-((5-(4,5-dimethyl-2-nitrophenyl)-2-furanyl)methylene)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl)benzoic acid | increases expression | 1 |
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Amiloride | affects binding, decreases activity | 1 |
| Arsenic | decreases expression, increases abundance | 1 |
| Vehicle Emissions | decreases reaction, increases expression | 1 |
| Benzo(a)pyrene | affects methylation, decreases methylation | 1 |
| Lead | increases expression | 1 |
| Methapyrilene | decreases methylation | 1 |
| Niclosamide | increases expression | 1 |
| Ozone | increases oxidation, increases expression | 1 |
| Plant Extracts | decreases expression, affects cotreatment | 1 |
| Smoke | decreases expression | 1 |
| Sodium | affects binding, increases transport | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Urethane | decreases expression | 1 |
| Valproic Acid | increases methylation | 1 |
| 2,4-Dichlorophenoxyacetic Acid | decreases expression | 1 |
Cellosaurus cell lines
3 cell lines: 2 cancer cell line, 1 transformed cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_B2ET | Abcam HeLa SCNN1D KO | Cancer cell line | Female |
| CVCL_TK17 | HAP1 SCNN1D (-) | Cancer cell line | Male |
| CVCL_YA80 | IDG-HEK293T-SCNN1D-V5-OE | Transformed cell line | Female |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): inflammatory bowel disease, ulcerative colitis